AXT and CELLINK Form a Formidable Australian Bioprinting Partnership

FHS
July 25, 2023
5:46 am

3D bioprinting is experiencing rapid growth as the technology continues to evolve. This is certainly the case in Australia and AXT, who are already well entrenched in the field are pleased to announce that they are strengthening their position by partnering with CELLINK.

BMS and Prime ink potential $3.5bn deal to develop T cell therapies – Pharmaceutical Technology

Ex vivo gene therapy offers a potential one-time, curative solution for a host of genetic diseases. Image: Getty Images/ Perception7 Bristol Myers Squibb (BMS) has

October 1, 2024

Short, daily reflection sessions help health care workers combat burnout

Watching short, web-based tutorials that inspire health care workers to contemplate awe, gratitude and kindness can promote enduring improvements in mental health outcomes such as

December 10, 2024

Could Psoriasis Treatment Be This Simple?

A derivative of the diuretic drug amiloride (Midamor) blocked key inflammatory pathways in mouse models of psoriasis, including xenografts of psoriatic human skin, as well

December 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.